The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York CJC 1295, Ipamorelin and Retatrutide: UK Safety and Legal Guide Bolt Pharmacy RFK Jr. wants Americans to use peptides that were banned over safety risks Ars Technica BREAKING: RFK just announced on Joe Rogan that ~14 of the 19 peptides banned from legal compounding in 2023 are coming back. Already under formal FDA review: CJC 1295, Ipamorelin, Thymosin Alpha 1, AOD 9604, Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives